May / June 2021
Features
How imaging is advancing management of dry AMD
Emerging modalities and deep learning are helping to expose an old foe in non-neovascular age-related macular degeneration: reticular pseudodrusen.
Imaging biomarkers and precision medicine
Advances in computational power, and machine learning and diagnostic systems are creating new opportunities for understanding disease mechanisms.
Where genetics, diet and drusen size intersect
A close look at research into how diet may reverse the effect of genetic susceptibility in drusen size progression in age-related macular degeneration.
Will biosimilars find their place in retina?
With patents expiring, an approval pending and legislation aimed at easing regulations, more biosimilars could be coming. But are retina specialists ready?
Departments
Clinical Trial Closeup
How THR-149 targets alternate pathway
The plasma kallikrein inhibitor is being investigated to treat diabetic macular edema that doesn’t respond to anti-VEGF therapy.
Coding Commentary
Clearing up E/M ‘clarifications’
The AMA issued new evaluation and management guidelines that can be hard to appreciate.
Editor's Page
Imaging Forum
Retinal sequelae of novel oncology drugs
Getting to the cause of blurred vision in a man with Erdheim-Chester disease.
News
Surgical Pearl Video
Pearls for epiretinal membrane peeling
Proper visualization and positioning are key to achieving a successful peel.
Uveitis Forum
Taking treatment beyond adalimumab
An update on biologic alternatives for ocular inflammatory disease when the approved agent just won’t cut it.
Current Issue
Continuing Medical Education
Additional Publications
Learn More about Stargardt Disease
Watch the webinar
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
